CellWell record HH-522500
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study
Herbst AL; Anderson S; Hubby MM; Haenszel WM; Kaufman RH; Noller KL
American journal of obstetrics and gynecology ยท 1986
In plain language
In a case-control study, clear cell adenocarcinoma risk after diethylstilbestrol exposure was higher when maternal dosing began before twelve weeks of pregnancy, and with a prior maternal spontaneous abortion.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-522500
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.